ELEVATEBIO
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's most innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.
ELEVATEBIO
Industry:
Biotechnology
Founded:
2017-01-01
Status:
Active
Contact:
617-433-2600
Email Addresses:
[email protected]
Total Funding:
845 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Biofourmis
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Catamaran Bio
Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-27 | Life Edit | Life Edit acquired by ElevateBio | N/A |
Investors List
EDBI
EDBI investment in Series C - ElevateBio
Emerson Collective
Emerson Collective investment in Series C - ElevateBio
Samsara BioCapital
Samsara BioCapital investment in Series C - ElevateBio
Surveyor Capital
Surveyor Capital investment in Series C - ElevateBio
ITOCHU Corporation
ITOCHU Corporation investment in Series C - ElevateBio
Redmile Group
Redmile Group investment in Series C - ElevateBio
Vertex Ventures
Vertex Ventures investment in Series C - ElevateBio
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - ElevateBio
Invus
Invus investment in Series C - ElevateBio
F2 Ventures
F2 Ventures investment in Series C - ElevateBio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | AlloVir | ElevateBio investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2021-06-23 | Abata Therapeutics | ElevateBio investment in Series A - Abata Therapeutics | 95 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | ElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development |
| 2020-03-05 | ElevateBio Appoints Kareem Reda as Chief Business Officer |
More informations about "ElevateBio"
About Us - ElevateBio
ElevateBio is a technology-driven cell and gene therapy company, accelerating access to the cutting-edge technologies and expertise to change the future of medicine.See details»
ElevateBio - Crunchbase Investor Profile & Investments
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies. View contacts for ElevateBio to access new leads and connect with decision-makers.See details»
ElevateBio Company Profile 2024: Valuation, Funding
Operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines.See details»
Our Ecosystem - ElevateBio
We are a technology-driven cell and gene therapy company, accelerating access to the cutting-edge technologies and expertise that will change the future of medicine.See details»
ElevateBio: Revenue, Competitors, Alternatives - Growjo
Many Companies ￃﾢ￢ﾂﾬ￢ﾀﾜ One Robust Organization ElevateBioￃﾢ￢ﾂﾬ￢ﾄﾢs novel business model, including BaseCamp, our centralized R&D and manufacturing …See details»
ElevateBio - Overview, News & Similar companies | ZoomInfo.com
Xcell Biosciences Announces Collaboration with ElevateBio to Advance Technology Development for Cell and Gene Therapies SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences, Inc. …See details»
ElevateBio - Contacts, Employees, Board Members, Advisors
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.See details»
ABOUT ELEVATEBIO - Cell and Gene
ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come.See details»
ElevateBio Company Profile - Office Locations, Competitors ... - Craft
ElevateBio is a company focused on creating and operating a portfolio of cell and gene therapy companies to develop, manufacture and commercialize life-transforming medicines.See details»
ElevateBio - themedicinemaker.com
ElevateBio was founded in 2017 by David Hallal, Vikas Sinha, and Mitchell Finer. The goal was to help drug companies accelerate their cell and gene therapies through technologies, such as gene editing, induced pluripotent stem cells, …See details»
ElevateBio Launches to Create and Operate a Portfolio of Highly ...
Cambridge, Mass. – May 13, 2019 – ElevateBio, a Cambridge-based biotechnology holding company, today announced operations to create and build a broad portfolio of cell and gene …See details»
ElevateBio proposes centralized model for cell & gene startups
May 15, 2019 Recently launched through a $150 million (€134 million) Series A financing, ElevateBio intends to create and grow a portfolio of cell and gene therapy companies using …See details»
ElevateBio nets $525M to bolster cell, gene therapy platform
Mar 15, 2021 After launching multiple companies and signing some partners, ElevateBio is grabbing another $525 million to fuel its work in cell and gene therapy. The funds will bolster …See details»
ElevateBio finds a new manufacturing home and long-term gene …
Aug 25, 2022 ElevateBio, a privately held biotechnology company that’s raised hundreds of millions of dollars from private investors, signed a 30-year partnership with the University of …See details»
ElevateBio is one of the most innovative biotech companies of 2024
Mar 19, 2024 Explore the full 2024 list of Fast Company’s Most Innovative Companies, 606 organizations that are reshaping industries and culture. We’ve selected the firms making the …See details»
ElevateBio raises funds to advance cell and gene therapies
Jun 1, 2023 ElevateBio has raised $401m in a Series D financing round for advancing its technology platforms to expedite the design, production and development of cell and gene …See details»
ElevateBio Formed to Create Portfolio of Cell & Gene
May 26, 2019 CAMBRIDGE, Mass. — ElevateBio, a Cambridge-based biotechnology holding company, today announced operations to create and build a broad portfolio of cell and gene …See details»
ElevateBio Announces $401 Million Series D Financing to Further ...
May 24, 2023 ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come.See details»
ElevateBio hits 2023 high with $401M for cell, gene therapies
May 24, 2023 ElevateBio’s $401 million haul has already knocked the RNA company’s $300 million series A off the fundraising top spot after just one day. ElevateBio hits 2023 high with …See details»